Medical research

Multiple sclerosis drug works in a surprising way

Drugs called interferon betas are common treatments for multiple sclerosis (MS), reducing relapses and slowing motor function decline. Interferon beta, a protein known to contain a zinc binding pocket, is thought to reduce ...

Oncology & Cancer

A potential new cancer target

The role of transforming growth factor beta (TGF-beta) in cancer progression is still not fully understood due its context-dependent biology.

page 4 from 10